OTCMKTS:MAHLY

MediPal (MAHLY) Stock Price, News & Analysis

$15.22
0.00 (0.00%)
(As of 05/10/2024 ET)
Today's Range
$15.22
$15.22
50-Day Range
$15.22
$15.54
52-Week Range
$15.22
$17.19
Volume
N/A
Average Volume
863 shs
Market Capitalization
N/A
P/E Ratio
0.16
Dividend Yield
149.84%
Price Target
N/A

About MediPal

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Further, the company trades in medical clerks; outsourcing of medical administrative, and medical consulting; and distributes specialty pharmaceuticals. Additionally, it engages in contract logistics services, as well as offers information provision services. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. The company was founded in 1898 and is headquartered in Tokyo, Japan.

MAHLY Stock Price History

MAHLY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive MAHLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediPal and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Distribution
Sub-Industry
N/A
Current Symbol
OTCMKTS:MAHLY
CIK
N/A
Fax
N/A
Employees
12,795
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Shuichi Watanabe (Age 72)
    Chief Compliance Officer, CEO, President & Representative Director
  • Mr. Yuji Sakon (Age 71)
    MD, GM of Administration Division & Director
  • Mr. Toshihide Yoda (Age 61)
    Senior MD of Investor Relations, GM of Business Development Department & Director
  • Mr. Yasuhiro Choufuku (Age 70)
    Executive VP & Director
  • Mr. Shinjiro Watanabe (Age 52)
    GM of Information Systems Management Division & Director

MAHLY Stock Analysis - Frequently Asked Questions

Should I buy or sell MediPal stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MediPal in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" MAHLY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MAHLY, but not buy additional shares or sell existing shares.
View MAHLY analyst ratings
or view top-rated stocks.

How have MAHLY shares performed in 2024?

MediPal's stock was trading at $16.40 at the start of the year. Since then, MAHLY shares have decreased by 7.2% and is now trading at $15.2205.
View the best growth stocks for 2024 here
.

Are investors shorting MediPal?

MediPal saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 1,800 shares, an increase of 125.0% from the March 15th total of 800 shares. Based on an average daily trading volume, of 200 shares, the days-to-cover ratio is currently 9.0 days.
View MediPal's Short Interest
.

Is MediPal a good dividend stock?

MediPal (OTCMKTS:MAHLY) pays an annual dividend of $22.81 per share and currently has a dividend yield of 1.92%. The dividend payout ratio is 23.88%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of MediPal?

Shares of MAHLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MAHLY) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners